<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01465594</url>
  </required_header>
  <id_info>
    <org_study_id>catheterstudy001</org_study_id>
    <nct_id>NCT01465594</nct_id>
  </id_info>
  <brief_title>Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy</brief_title>
  <official_title>Randomized Study Comparing Urinary Diversion by Suprapubic Catheter With Transurethral Catheter in Patients After Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to show the technical feasibility of the suprapubic urinary diversion after&#xD;
      endoscopic extraperitoneal radical prostatectomy (EERPE) and has a greater comfort for the&#xD;
      patients with at least the same catheter complication rate in comparison to the urethral&#xD;
      urinary diversion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are randomized 1:1 in the different arms Recording of QoL measured by visual&#xD;
      analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate,&#xD;
      complication rate regarding insufficiency and strictures of vesicourethral anastomoses and&#xD;
      urinary tract infection; demand of re-catheterization due to urinary retention and demand of&#xD;
      antispasmodics&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Superiority of suprapubic catheter after EERPE</measure>
    <time_frame>2nd postoperative day</time_frame>
    <description>Superiority of suprapubic catheter versus transurethral catheter regarding QoL /Patient comfort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of QoL in both arms measured by visual analogue (pain) scale</measure>
    <time_frame>1st and 3rd until 5th postoperative day</time_frame>
    <description>Comparison of QoL in both arms measured by visual analogue (pain) scale, EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Pain</condition>
  <condition>Catheter Complications</condition>
  <arm_group>
    <arm_group_label>transurethral catheter after EERPE/ RALP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Recording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>suprapubic catheter after EERPE /RALP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Recording of QoL measured by visual analogue ( pain )scale,EORTC QlQ -C 30 and QLQ - PR 25 questionnaires, incontinence rate, complication rate regarding insufficiency and strictures of vesicourethral anastomoses and urinary tract infection; demand of re-catheterization due to urinary retention and demand of antispasmodics</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transurethral catheter after EERPE/ RALP</intervention_name>
    <description>transurethral catheter after EERPE/ RALP</description>
    <arm_group_label>suprapubic catheter after EERPE /RALP</arm_group_label>
    <arm_group_label>transurethral catheter after EERPE/ RALP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>suprapubic catheter after EERPE /RALP</intervention_name>
    <description>suprapubic catheter after EERPE /RALP</description>
    <arm_group_label>suprapubic catheter after EERPE /RALP</arm_group_label>
    <arm_group_label>transurethral catheter after EERPE/ RALP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adenocarcinoma of the prostate,&#xD;
&#xD;
          -  Subjects treated by conventional or robotic assisted laparoscopic prostatectomy&#xD;
&#xD;
          -  Be willing/able to adhere to follow up visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects treated by retropubic or perineal prostatectomy Subjects with known bladder&#xD;
             cancer&#xD;
&#xD;
          -  Contraindications for anticholinergic drugs&#xD;
&#xD;
          -  Waist measurement &gt; 100 cm&#xD;
&#xD;
          -  No written informed consent&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Subjects with known narrow-angle glaucoma&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Arsov, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich Heine Universität</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Urological department</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>November 2, 2011</study_first_submitted>
  <study_first_submitted_qc>November 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2011</study_first_posted>
  <last_update_submitted>May 19, 2015</last_update_submitted>
  <last_update_submitted_qc>May 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain Measurement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

